Inovio Biomedical Partner Tripep Files Application For Phase I Clinical Study Of Hepatitis C DNA Vaccine

Sat, 09 Dec 2006 06:00 PM EST

... Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced recently that its partner, Tripep AB of Sweden, has filed an application for a phase I clinical study with the Swedish Medical Products Agency. [click link for full article] ...